![The Effects of Celecoxib or Naproxen on Blood Pressure in Pediatric Patients with Juvenile Idiopathic Arthritis - B. Falkner, M. Berger, P. Bhadra Brown, D. Iorga, R.W. Nickeson, L. Zemel, 2015 The Effects of Celecoxib or Naproxen on Blood Pressure in Pediatric Patients with Juvenile Idiopathic Arthritis - B. Falkner, M. Berger, P. Bhadra Brown, D. Iorga, R.W. Nickeson, L. Zemel, 2015](https://journals.sagepub.com/cms/10.4137/CMPed.S20720/asset/images/large/10.4137_cmped.s20720-fig3.jpeg)
The Effects of Celecoxib or Naproxen on Blood Pressure in Pediatric Patients with Juvenile Idiopathic Arthritis - B. Falkner, M. Berger, P. Bhadra Brown, D. Iorga, R.W. Nickeson, L. Zemel, 2015
![Pharmacokinetics, Tissue Distribution, Metabolism, and Excretion of Celecoxib in Rats | Drug Metabolism & Disposition Pharmacokinetics, Tissue Distribution, Metabolism, and Excretion of Celecoxib in Rats | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/28/5/514/F4.large.jpg)
Pharmacokinetics, Tissue Distribution, Metabolism, and Excretion of Celecoxib in Rats | Drug Metabolism & Disposition
![These highlights do not include all the information needed to use CELECOXIB CAPSULES safely and effectively. See full prescribing information for CELECOXIB CAPSULES. CELECOXIB capsules, for oral use Initial U.S. Approval: 1998 These highlights do not include all the information needed to use CELECOXIB CAPSULES safely and effectively. See full prescribing information for CELECOXIB CAPSULES. CELECOXIB capsules, for oral use Initial U.S. Approval: 1998](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=container-label-50mg-1000packs.jpg&id=676394)
These highlights do not include all the information needed to use CELECOXIB CAPSULES safely and effectively. See full prescribing information for CELECOXIB CAPSULES. CELECOXIB capsules, for oral use Initial U.S. Approval: 1998
Celecoxib: a review of its use in the management of arthritis and acute pain - Document - Gale OneFile: Health and Medicine
![These highlights do not include all the information needed to use CELECOXIB CAPSULES safely and effectively. See full prescribing information for CELECOXIB CAPSULES. CELECOXIB capsules, for oral use Initial U.S. Approval: 1998 These highlights do not include all the information needed to use CELECOXIB CAPSULES safely and effectively. See full prescribing information for CELECOXIB CAPSULES. CELECOXIB capsules, for oral use Initial U.S. Approval: 1998](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=celecoxib-400mg-60s-bottle.jpg&id=687544)
These highlights do not include all the information needed to use CELECOXIB CAPSULES safely and effectively. See full prescribing information for CELECOXIB CAPSULES. CELECOXIB capsules, for oral use Initial U.S. Approval: 1998
![Celecoxib Plasma Concentration-time Curve. Plasma concentration-time... | Download Scientific Diagram Celecoxib Plasma Concentration-time Curve. Plasma concentration-time... | Download Scientific Diagram](https://www.researchgate.net/publication/314300625/figure/fig7/AS:613991466414126@1523398381877/Celecoxib-Plasma-Concentration-time-Curve-Plasma-concentration-time-profile-of-celecoxib.png)
Celecoxib Plasma Concentration-time Curve. Plasma concentration-time... | Download Scientific Diagram
![Lessons from 20 years with COX‐2 inhibitors: Importance of dose–response considerations and fair play in comparative trials - Stiller - 2022 - Journal of Internal Medicine - Wiley Online Library Lessons from 20 years with COX‐2 inhibitors: Importance of dose–response considerations and fair play in comparative trials - Stiller - 2022 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/21bff47b-52e2-4d1f-b271-23ecf9014267/joim13505-fig-0003-m.jpg)
Lessons from 20 years with COX‐2 inhibitors: Importance of dose–response considerations and fair play in comparative trials - Stiller - 2022 - Journal of Internal Medicine - Wiley Online Library
![Safety of Celecoxib in patients with cutaneous reactions due to ASA-NSAIDs intolerance | Allergologia et Immunopathologia Safety of Celecoxib in patients with cutaneous reactions due to ASA-NSAIDs intolerance | Allergologia et Immunopathologia](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/13108222:105v35n04-13108222tab02.gif?idApp=UINPBA00004N)
Safety of Celecoxib in patients with cutaneous reactions due to ASA-NSAIDs intolerance | Allergologia et Immunopathologia
![Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib | Annals of the Rheumatic Diseases Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/63/11/1419/F3.large.jpg)
Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib | Annals of the Rheumatic Diseases
![Impact of Hydroxypropyl Methylcellulose Acetate Succinate Critical Aggregation Concentration on Celecoxib Supersaturation | Molecular Pharmaceutics Impact of Hydroxypropyl Methylcellulose Acetate Succinate Critical Aggregation Concentration on Celecoxib Supersaturation | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.1c00372/asset/images/medium/mp1c00372_0008.gif)
Impact of Hydroxypropyl Methylcellulose Acetate Succinate Critical Aggregation Concentration on Celecoxib Supersaturation | Molecular Pharmaceutics
![Pharmaceutics | Free Full-Text | Preparation and Evaluation of Amino Acid Conjugates of Celecoxib as Prodrugs to Improve the Pharmacokinetic and Therapeutic Properties of Celecoxib Pharmaceutics | Free Full-Text | Preparation and Evaluation of Amino Acid Conjugates of Celecoxib as Prodrugs to Improve the Pharmacokinetic and Therapeutic Properties of Celecoxib](https://www.mdpi.com/pharmaceutics/pharmaceutics-12-01043/article_deploy/html/images/pharmaceutics-12-01043-g003-550.jpg)